U.S. Gas Utilities Stock News

Violent swings in US Treasury yields are rippling across markets, reshaping funding costs, bond valuations, and liquidity for companies that lean heavily on government debt markets. When borrowing costs jump and trading conditions turn choppy, some stocks can struggle with squeezed margins, pressured client activity, or balance sheets that are more exposed than they look at first glance. This article focuses on the risks, not the potential winners. It does this by breaking down 3 stocks from...

Morningstar, Inc. recently announced that its Morningstar Wealth division is working with Apollo Global Management, Franklin Resources, and J.P. Morgan Asset Management to create research-driven public/private model portfolios for financial advisors, while its board affirmed a quarterly dividend of US$0.50 per share payable on July 31, 2026. This collaboration aims to broaden access to private markets for individual investors by packaging private credit and real estate exposure into...

Earlier in June 2026, Viatris Inc. completed a €650 million offering of 4.250% fixed-rate senior unsecured Eurobonds due June 17, 2033, priced at 99.739% of face value with attached guarantees and callable features. This move adds a new layer to Viatris’ capital structure just as investors are focusing on its late-stage product pipeline, free cash flow above US$2.20 billion, and value-focused analyst ratings. We’ll now examine how Viatris’ fresh Eurobond issuance interacts with its...

Cisco Systems (CSCO) has moved into focus after Equinix expanded its work with Cisco and NVIDIA on the Secure AI Factory, alongside Cisco’s founding role in Rotterdam’s new Quantum Communication Fieldlab. See our latest analysis for Cisco Systems. Cisco Systems’ recent collaborations around the Secure AI Factory and quantum-secure networking come as the share price trades at US$121.15, with a 90-day share price return of 48.05% and a 1-year total shareholder return of 82.56%. This points to...

Earlier this year, Regency Centers reported first-quarter funds from operations of US$1.20 per share, falling short of analyst expectations and pairing that with full-year FFO guidance of US$4.83 to US$4.87 per share that signaled management caution. This combination of an earnings miss and a restrained outlook has become a focal point for investors reassessing the resilience of its grocery-anchored retail portfolio. We’ll now examine how this first-quarter FFO shortfall and more cautious...

On June 22, 2026, Wolfe Research upgraded Kimco Realty to Outperform, highlighting the REIT’s strong fundamentals and easing refinancing pressures following its recent US$525 million exchangeable notes offering. The upgrade underscores how Kimco’s focus on strengthening its balance sheet and funding growth initiatives is reshaping investor confidence in its retail real estate model. Now we’ll examine how reduced refinancing pressure and balance sheet moves influence Kimco’s existing...

Greg Abel, the new CEO of Berkshire Hathaway (NYSE:BRK.B), has led major portfolio changes, including new investments in Macy's, Delta Air Lines, and Alphabet. The company has also tripled its stake in the New York Times and agreed to acquire homebuilder Taylor Morrison. These moves come as Berkshire refines its equity portfolio and continues to use share buybacks to align with shareholders. Berkshire Hathaway operates as a diversified holding company with large insurance, energy,...

One broker sees substantial upside in the Virtuix stock price, but the forecast depends on military adoption, stronger demand and future funding discipline.

Chemed recently reported quarterly results that exceeded analysts’ expectations on both revenue and earnings per share, driven by performance at its VITAS hospice and Roto-Rooter plumbing businesses. This outperformance highlights how Chemed’s combination of healthcare services and essential home maintenance can provide relatively resilient cash flow across different economic conditions. We’ll now explore how Chemed’s stronger‑than‑expected earnings, particularly from VITAS hospice and...

Earlier this month, SentinelOne Inc. expanded its AI-native cybersecurity platform by opening Purple AI Agentic Investigation to customers, launching Singularity Credits for AI-powered workloads, and announcing an upcoming integration of its Prompt Security offering with Amazon Bedrock AgentCore on AWS. Together, these moves deepen SentinelOne’s role in securing enterprise AI agents and workflows, tying autonomous threat investigation directly into a major cloud ecosystem while unifying how...

Alan Greenspan’s death at 100 has pushed Federal Reserve history and monetary policy back into the spotlight, and that matters for some of the biggest financial stocks on your watchlist. When markets recheck old assumptions about interest rates, transparency and central bank credibility, large US banks, asset managers and insurers can see sentiment move quickly. This article looks at how that news connects to today’s US financial heavyweights and what it might mean for investors weighing...

Morgan Stanley’s upgrade of CDW (CDW) to Overweight, tied to resilient enterprise server demand and accelerated AI infrastructure spending, has refocused attention on the stock and its recently announced US$1 billion share buyback. See our latest analysis for CDW. The 1 day share price return of 5.25% following Morgan Stanley’s upgrade comes after a 30 day share price return of 17.36%. Over the same period, the 1 year total shareholder return is down 26.28%, suggesting short term momentum has...

Knowles (KN) is in focus after the company expanded its range of high performance capacitors for pulse power applications, while also committing more resources to testing, process control, and live demonstrations at upcoming industry conferences. See our latest analysis for Knowles. Despite a sharp 6.33% decline in the 1 day share price return to US$40.09, Knowles still carries strong momentum, with a 30 day share price return of 9.36% and a 1 year total shareholder return of 127.91%. This...

Energy headlines are suddenly front and center again, with progress in US Iran talks, loosened export restrictions and a direct communication channel in the Strait of Hormuz all pointing to the possibility of more stable oil flows and extra supply pressure on crude prices. For airlines and transportation stocks that live with fuel as a major cost line, that combination can matter just as much as passenger demand. This article looks at how those developments and the current technical weakness...

Earlier this month, Lineage’s Board of Directors declared a second-quarter 2026 cash dividend of US$0.5325 per share, payable on July 21 to shareholders of record as of June 30, even as the company managed an extended fire at its Boyle Heights cold storage warehouse that triggered emergency responses across Los Angeles. The prolonged warehouse fire, reportedly sparked by rooftop solar work and reaching an ammonia line, has raised questions about Lineage’s safety practices and community...

Lyft (LYFT) is back in focus after Rothschild & Co Redburn shifted its view on the stock, pointing to ride growth pressures as temporary and highlighting expectations around the company’s international expansion plans. See our latest analysis for Lyft. At a share price of $13.82, Lyft has seen its 1 day share price return slip 2.81% and its 7 day share price return ease 3.22%. A 90 day share price return of 4.22% contrasts with a weaker year to date share price return, and the 3 year total...

Charter Communications’ removal from the NASDAQ-100 Index, announced on 19 June 2026, follows its earlier move to let Spectrum customers purchase Netflix directly through The Spectrum App Store. This combination of index exclusion and deeper integration of third-party streaming apps highlights how Charter’s capital markets profile and product ecosystem are evolving in different directions. We’ll now examine how Charter’s NASDAQ-100 exit could influence its broadband-focused investment...

Regeneron Pharmaceuticals (REGN) has drawn investor attention after recent trading that leaves the stock down about 3% over the past month and roughly 18% over the past 3 months, despite positive trailing 1 year returns. See our latest analysis for Regeneron Pharmaceuticals. Against this backdrop, Regeneron Pharmaceuticals shows fading near term momentum, with the share price down about 20% year to date, yet a 1 year total shareholder return of roughly 19% still points to a stronger longer...

In recent days, Monarch Casino & Resort has drawn increased attention as analysts highlighted strong technical momentum signals and reiterated favorable rankings for the stock, underpinned by multiple buy indications and positive earnings estimate revisions. Alongside this rising analyst enthusiasm, the company’s Atlantis Casino Resort Spa brand campaign has added to its profile by earning national creative and video awards, reinforcing the appeal of its Northern Nevada hospitality...

CACI International Inc. recently appointed Dr. Dave Young, age 45, as Executive Vice President and Chief Operating Officer, adding him to the executive leadership team reporting directly to the CEO after senior roles at Lockheed Martin, CAES, and Northrop Grumman. Young’s prior responsibility for a roughly US$7.00 billion national security space business and thousands of staff could meaningfully influence how CACI runs its operations and executes on complex defense and intelligence...

AI Small Caps are attracting attention as global data points point to mixed growth, easing but still sticky inflation, and constant focus on interest rates and energy costs. While large AI giants grab headlines, this AI Small Caps screener looks for earlier stage companies working in areas like machine learning, automation, and data intelligence that could benefit as businesses search for efficiency and smarter decision tools. In this article, you will see three of the top stocks from the...

Political spending around AI regulation is exploding, and that is turning compliance, security, and governance into real business for some companies. As lawmakers weigh tighter rules and Big Tech steps up lobbying, investors are starting to look at stocks that could benefit from higher regulatory focus rather than be squeezed by it. This article breaks down how that New York primary fight on AI rules ties back to your portfolio and highlights 3 stocks from an AI Regulation Beneficiaries...

Immunome, Inc. recently dosed the first patient in a Phase 1, first-in-human trial of IM-1617, a potential first-in-class antibody-drug conjugate for advanced solid tumors, incorporating its proprietary TOP1 inhibitor payload HC74. The trial advances Immunome’s antibody-drug conjugate platform by targeting an undisclosed receptor tyrosine kinase linked to tumor survival and immune cell exclusion, with additional IND filings for IM-1340 and IM-1335 planned for mid- and late 2026. We will now...

Hexcel (HXL) has drawn fresh attention after Deutsche Aircraft signed a long-term partnership for composite materials on the D328eco regional turboprop, which ties the stock story more closely to Europe’s sustainable aviation ambitions. See our latest analysis for Hexcel. Despite a recent pullback, with a 1-day share price return down 3.07% and a 7-day share price return down 2.31%, Hexcel’s 30-day and year-to-date share price returns of 11.52% and 25.03%, plus a 1-year total shareholder...